Dr. Margot Morssinkhof

Thanks to the Amsterdam University Fund, and many thanks to my colleagues, supervisors and @NederlandPMDD for their valuable input. I'm really excited about starting this project! Do you have good ideas, input or want to know more about the TIDE project? Do let me know 📩!

With the TIDE project, I hope we can gain a better understanding of how many people with depression suffer from premenstrual exacerbation of their symptoms. We will also study whether it is clinically relevant for treatment providers to do daily symptom tracking across the cycle.

I am very excited to have received an Amsterdam UMC Startstipendium grant! With this grant, I will set up a new study on premenstrual exacerbation (PME) in depression: the TIDE project. A short thread on PME and the project 🧵:

So proud of our symposium yesterday at @wpath on psychosocial and social health outcomes after gender-affirming hormones. Amazing presentations from @NessaMillet1 @HormonoGo from @AffirmRelation and @DrBrendanNolan1. This work is so important to healthcare equity for trans people

@nifti12 @ERC_Research Congratulations, that's amazing 🥳🥳🥳!!

@AM_Doornweerd Ahh very cool study, congrats on the preprint! 🥳

What happens when you follow the menstrual cycle and collect daily well-being reports and salivary samples? Our new pre-print!

This study was partially intended as a pilot study for the work we will do in the Affirm Relationships project, in which we will study social and psychological well-being using more diary-style and EMA measuremements. Make sure to follow @AffirmRelation to stay up to date 📣!

Since we're still in the preprint phase, let us know if you have any thoughts on the study! Happy to talk about any improvements we could make in the manuscript 💡.

We measured variability through calculation of the iSD, meaning the within-measurement SD of the day-to-day affect outcomes. As shown below, participants with the same mean affect level can show large differences in affect variability when assessing the iSD.

In the RESTED study, we asked participants to complete daily diaries, which included items on negative mood. Using these items, we assessed whether day-to-day variability in reported negative affect showed changes after 3 and 12 months of gender-affirming hormones.

NEW PREPRINT! 🥳 I’m very excited about our new preprint, in which we report on changes in affect variability in transgender people starting gender-affirming hormones: medrxiv.org/content/10.110… A short thread on our study setup and results below 🧵:

Affect variability is the degree to which our emotions fluctuate over time. Trans people have reported changes in emotionality after starting gender-affirming hormones, including “flattening” of emotions after masculinizing hormones and deeper emotions after feminizing hormones.

@NessaMillet1 @amsterdamumc Happy Amsterdammiversary, so happy to have you here🫶🏻✨️!

Well, time flies! Exactly one year ago I moved my life to the land of fietsen and bitterballen and continued my academic journey working at @amsterdamumc. Thankfully I have been doing so with a smile and no regrets 😊

With warm thanks to my supervisors and opponents for the time and attention dedicated to my thesis and defense!

I had the best day, thanks to sweet friends, family and colleagues who spoiled me with the coolest personal gifts 🫶🏻

PhDone! After defending my thesis yesterday, I'm officially going by Dr. Margot now 👩🏼‍🎓🥹